Skip to main content

Advertisement

Table 1 Descriptive statistics demonstrate patient characteristics and outcomes of MIAMBE technique in the selected studies

From: Is antral membrane balloon elevation truly minimally invasive technique in sinus floor elevation surgery? A systematic review

Study Patients Age (years) N of sinus augmentation Sinus augmentation success rate % Baseline bone height (mm) Bone gain (mm) Antral membrane elevation (mm) Total bone height (mm) Inflate balloon volume Type of graft Membrane perforation Test for membrane perforation Complications Follow-up period after operation
N M:F R M N PR %
Kfir et al. [5] 12 NM 42 ± 9 NM 91.6 3.7 ± 1.4 NM > 10 10–17 ≤ 2.5 mL -PRF -ABP -Bi-Ostetic synthetic bone graft 1 8.33 Valsalva maneuver Direct visualization 1 membrane tear 1 balloon rupture 1 implant failed 23 months
12 NM NM 100 3.5 ± 1.3 NM > 10 10–18 0 0 1 mild periprocedural nosebleed 12 months
Kfir et al. [29] 36 M = 18 F: 18 42 ± 9 36 97.2 3.4 ± 2.1 NM > 10 8–18 NM -PRF -ABP -Bi-Ostetic Synthetic bone graft -Fisiograft gel 1 2.77 Valsalva maneuver 1 membrane tear 2 implant failed 6–8 months
Hu et al. [30] 28 M = 143 F = 14 40.2 ± 12.35 28 92.85 4.92 ± 1.24 NM Mean 10.9 ± 2.06 NM 0.67 ± 0.17 mL -PRF -Bio-Oss 2 7.14 Valsalva maneuver 1 mild nosebleed after surgery 2 membrane tear and the cases aborted 15.9 ± 2.94 months.
Kfir et al. [31] 112 M = 50 F = 62 44.1 ± 12.9 NM 97.3% initial procedural success 100% secondary procedural success 3.8 ± 2.1 NM > 10 11–18 NM -PRF -Synthetic bone graft -ABP -Fisiograft gel 12 10.71 Valsalva maneuver Direct visualization 1 infection and oroantral fistula at 4 weeks 3 membrane tear and the procedures aborted 9 micropuncture 13 months
Mazor et al. [32] 20 NM 37–72 24 100 2–6 NM 11 NM NM -PRF -Synthetic bone substitute 0 0 Valsalva maneuver Direct visualization 1 patient was allergic to the antibiotic 18 months
Petruzzi et al. [33] 40 M = 16 F = 24 41.5 NM NM 8.00 ± 2.19   0.6 ≤ 20 14.66 ± 1.48 1– ml Calcium sulphate solution 3 7.5 Microscope (KarlKaps) 1 m acrolaceration 2 m icrolacerations 4 hemifacial edema 1 year
Peñarrocha-Diago et al. [34] 6 M = 5 27–51 6 83.3% for the all 6 cases 100% for the five cases 2.1–4.1 7.2–10.8 8.7 NM 11.3–14.5 NM -ABP -BIO-OSS bovine bone grafts 1 16.66 (Medi Pack Pal) endoscope 1 membrane tear and case aborted 1 year after prosthetic loading
Gonzalez et al. [35] 14 M = 7 F = 7 NM NM 71.4 5.2   8.5 NM NM NM BIO-OSS bovine bone grafts 3 21.32 An operating microscope Failure of four cases due to mucosa perforation (21.32%) and balloon breakage (7.14%). 1 implant showed marginal periimplantitis which treated successfully 1 year
Dhandapani et al. [36] 9 NM 25–60 10 100 5–8 3–5.5 4.34 ≥ 10 13.5–9 1 cc Irradiated allogeneic cancellous bone and marrow graft 0 0 NM No complications 6 months
Asmael, and Lateef [37] 13 M = 4 F:9 28–57 17 100 2.3–7.8 4.9 –10.6 6.70 NM 9.8–17.2 0.5–1 cc Particulate bone grafts (βTricalcium Phosphate) 0 0 Direct vi ion Hydraulic pressure 1 mild nasal bleeding 1 infraorbital ecchymosis 1 year
Total : Average Total : Range      91.6 100–71.4%   6.968 3–10.8 mm      6.76 0–21.32%    
  1. MIAMBE minimally invasive antral membrane balloon elevation, N number, NM not mentioned, M:F male: female numbers, M mean, R range, PRF platelets rich fibrin, PRP platelets rich plasma, ABP autogenous bone particles, PR perforation rate